(Q22242643)

Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation

volume

16

0 references

issue

3

0 references

page(s)

143-149

0 references

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1076-7460.2007.06696.X

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease

20 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1076-7460.2007.06696.X

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

20 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1076-7460.2007.06696.X

Apolipoprotein E-epsilon 4 allele and familial risk in Alzheimer's disease

20 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

New frontiers in Alzheimer's disease genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Familial patterns of risk in very late-onset Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Vascular risk factors for Alzheimer's disease: an epidemiologic perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Association of diabetes mellitus and dementia: the Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Risk of dementia among persons with diabetes mellitus: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

The effect of borderline diabetes on the risk of dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Apolipoprotein-E genotyping of diabetic dementia patients: is diabetes rare in Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Diabetes and dementia in long-term care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Nonenzymatic glycosylation and the pathogenesis of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

[New hypothesis on etiopathogenesis of Alzheimer syndrome. Advanced glycation end products (AGEs)].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Glucose regulation and cognitive functions: relation to Alzheimer's disease and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Leptin and insulin action in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Blood glucose and brain function: interactions with CNS cholinergic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Memory improvement following induced hyperinsulinemia in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Clearing the brain's amyloid cobwebs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Elevated serum total and LDL cholesterol in very old patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

High total cholesterol levels in late life associated with a reduced risk of dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Statins and the risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Prevention and treatment of dementia or Alzheimer's disease by statins: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

The role of cholesterol in the biosynthesis of beta-amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Association of incident Alzheimer disease and blood pressure measured from 13 years before to 2 years after diagnosis in a large community study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Angiotensin Converting Enzyme in Alzheimer's Disease: Increased Activity in Caudate Nucleus and Cortical Areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Total homocysteine and cognitive deterioration in people with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Homocysteine in neuropsychiatric disorders of the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Homocysteine and cognitive function in the elderly: the Rotterdam Scan Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

A controlled trial of homocysteine lowering and cognitive performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Putative mechanisms for vascular damage by homocysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

NMDA-dependent superoxide production and neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Functional vitamin B(12) deficiency and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Dietary fat intake and the risk of incident dementia in the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Rectal diazepam gel for treatment of acute repetitive seizures in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Intake of flavonoids and risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Dietary intake of antioxidants and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Alcohol consumption and risk of dementia: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

The association between smoking and Alzheimer's disease: effects of study design and bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Predictors of cognitive change in older persons: MacArthur studies of successful aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Atrial fibrillation and dementia in a population-based study. The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Cardiac risk factors and potential treatments in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Cardiovascular disease and risk of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Cardiovascular disease and Alzheimer's disease: common links

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

7 January 2021

Low-Density Lipoprotein Cholesterol and the Risk of Dementia With Stroke

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

7 January 2021

Alzheimer's disease--synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

7 January 2021

15-year longitudinal study of blood pressure and dementia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

7 January 2021

B vitamins, homocysteine, and neurocognitive function in the elderly

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

7 January 2021

Homocysteine, B vitamin status, and cognitive function in the elderly

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

7 January 2021

Incidence and Risk Factors of Dementia in a Defined Elderly Japanese Population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

7 January 2021

Oxidative alterations in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

7 January 2021

Coagulation and fibrinolysis markers and risk of dementia. The Dutch Vascular Factors in Dementia Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

7 January 2021

Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

7 January 2021

Smoking and Alzheimer's disease: a review of the epidemiological evidence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1076-7460.2007.06696.X

7 January 2021

10.1111/J.1076-7460.2007.06696.X

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

4855207

4855207

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference